Numan
Latest round
- Series B
Last raised
- Jul 2025
Total raised
- $69M
Investors
- 8
About Numan
Vir Health Limited specializes in delivering health and wellness services, particularly for men. Founded in 2018 in London, UK, by Sokratis Papafloratos, the firm has engaged in 4 significant deals. Vir Health Limited offers a variety of health and wellness products aimed at addressing common health concerns. Their services include personalized blood tests and treatments for issues like erectile dysfunction and low testosterone, utilizing clinically-proven medications alongside consultations from medical professionals.27 mn. The company operates on a direct-to-consumer model, offering subscription-based health services that include personalized consultations and medication deliveries, ensuring a user-friendly experience and competitive pricing for their range of health solutions.
Who invested in Numan
8 investors across 4 rounds
See all investors in Numan
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Numan
Who invested in Numan?
Numan has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Numan raised?
Numan has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Numan last raise money?
Numan's most recent round on record is a Series B, in Jul 2025.
What does Numan do?
Vir Health Limited specializes in delivering health and wellness services, particularly for men.
Where is Numan headquartered?
Numan is headquartered in London, UK.
Which VCs invest in companies like Numan?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back healthcare it companies at Numan's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series B
Raising like Numan? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.